57
Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by health care providers. These statistics involve data related to a provider’s ability to deliver certain services or their compliance with long-term health care goals. The purpose of this document is to describe how each of the CQMs automatically tracked by RevolutionEHR are scored. To locate the CQM scorecard, navigate to Reports > Administration > Providers > Clinical Quality Measures. 2017 Clinical Quality Measures January 13, 2017 1 2017 Clinical Quality Measures

Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by health care providers. These statistics involve data related to a provider’s ability to deliver certain services or their compliance with long-term health care goals.

The purpose of this document is to describe how each of the CQMs automatically tracked by RevolutionEHR are scored. To locate the CQM scorecard, navigate to Reports > Administration > Providers > Clinical Quality Measures.

2017 Clinical Quality Measures January 13, 2017 �1

2017 Clinical Quality Measures

Page 2: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Diabetes: Eye Exam (NQF0055 / CMS131v5)

Denominator: Patients 18-75 years of age with diabetes and a visit during the measurement period. Numerator: Patients in the denominator who had at least one of the following:

1) A retinal or dilated eye exam by an eye care professional in the measurement period.• A “retinal or dilated examination” is an encounter where the Fundus test is used to document

at least one value.

2) A negative retinal exam (no evidence of retinopathy) by an eye care professional in the year prior to the measurement period

• “No evidence of retinopathy” is a Fundus test where both of the following are true for both eyes:• “Diab Ret Grd” is “None”• “DME Y/N” is “N”

Notes

• “Visit” is an encounter with at least one service with CPT code: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99337, 99385, 99386, 99387, 99395, 99396, 99397, 92002, 92004, 92012, 92014, G0438, G0439

• “Diabetes” ICD-10 codes can be found in Appendix A

2017 Clinical Quality Measures January 13, 2017 �2

Page 3: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Closing the Referral Loop: Receipt of Specialist Report (CMS50v5)

Denominator: Number of patients who were both referred by one provider to another during the measurement period as documented in the Referrals component and who had a visit during the measurement period.

Numerator: Number of patients in denominator for whom the referring provider received a report from the provider to whom the patient was referred

Notes

• “Visit” is an encounter with at least one service with CPT code: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99391, 99392, 99393, 99394, 99395, 99396, 99397, 99385, 99386, 99387, 99381, 99382, 99383, 99384, 92002, 92004, 92012, 92014

• “Received a report” requires the “Report Received” box in the Referrals component to be checked

2017 Clinical Quality Measures January 13, 2017 �3

Page 4: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Documentation of Current Medications in the Medical Record (NQF 0419 / CMS68v6)

Denominator: All visits occurring during the 12 month reporting period for patients aged 18 years and older before the start of the measurement period.

• An exception is available for medical reasons where the patient is in an urgent or emergent situation where time is of the essence and the delay of treatment would jeopardize the patient’s health status.

Numerator: Eligible professional attests to documenting, updating or reviewing the patient's current medications using all immediate resources available on the date of the encounter.

• “Attests to documenting” requires the provider to click “Review” on the Medications screen in the encounter prior to signing.

Notes

• “Visit” is an encounter with at least one service with CPT code: 90791, 90792, 90832, 90834, 90837, 90839, 92002, 92004, 92012, 92014, 92507, 92508, 92526, 92541, 92542, 92544, 92545, 92547, 92548, 92550, 92557, 92567, 92568, 92570, 92585, 92588, 92626, 96116, 96150, 96151, 96152, 97001, 97002, 97003, 97004, 97532, 97802, 97803, 97804, 98960, 98961, 98962, 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99385, 99386, 99387, 99395, 99396, 99397, 99495, 99496, G0101, G0108, G0270, G0402, G0438, G0439

• Allowed Clinical Exception SNOMED codes:

2017 Clinical Quality Measures January 13, 2017 �4

183932001 Procedure contraindicated (situation)

397745006 Medical contraindication (finding)

407563006 Treatment not tolerated (situation)

428119001 Procedure not indicated (situation)

Page 5: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Use of High-Risk Medications in the Elderly (NQF0022 / CMS156v5)

Denominator: Patients 66 years and older who had a visit during the measurement period.

Numerator 1: Patients with an order for at least one high-risk medication during the measurement period OR an order for at least one high-risk medication with days supply criteria with a cumulative medication duration > 90 days during the measurement period.

Numerator 2: Patients with an order for at least two different high-risk medications during the measurement period OR an order for at least two high-risk medication with days supply criteria with a cumulative medication duration > 90 days during the measurement period.

Notes:

• A lower score indicates better quality

• “Visit” is an encounter with at least one service with CPT code: 92002, 92012, 92004, 92014, 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99337, 99385, 99386, 99387, 99395, 99396, 99397, 92002, 92004, 92012, 92014, G0438, G0439

• “Cumulative medication duration” is an individual's total number of medication days over a specific period; the period counts multiple prescriptions with gaps in between, but does not count the gaps during which a medication was not dispensed.

• Example: a patient has an original prescription for 30 days with 2 refills for thirty days each. After a gap of 3 months, the medication was prescribed again for 60 days with 1 refill for 60 days. The cumulative medication duration is (30 x 3) + (60 x 2) = 210 days over the 10 month period.

• “High-risk medications” are listed in Appendix B

• “High-risk medications with days supply criteria” are listed in Appendix C

2017 Clinical Quality Measures January 13, 2017 �5

Page 6: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Surgery (NQF0565 / CMS133v5)

Denominator: All patients aged 18 years and older who had cataract surgery during but greater than 92 days prior to the end of the reporting period as documented within the Surgery History component.

• Patients with significant ocular conditions that impact the visual outcome of surgery are excluded.

Numerator: Patients who had best-corrected visual acuity of 20/40 or better (distance or near) achieved within 90 days following cataract surgery.

Notes

• “Cataract surgery” is a surgery with SNOMED code from Appendix D

• “Significant ocular conditions that impact the visual outcome or surgery” must start prior to surgical date and be active on day of surgery. They include:

Acute and Subacute Iridocyclitis, Pathologic Myopia, Retinal Detachment with Retinal Defect, Retinal Vascular Occlusion, Purulent Endophthalmitis, Certain Types of Iridocyclitis, Glaucoma Associated with Congenital Anomalies, Dystrophies, and Systemic Syndromes, Chronic Iridocyclitis, Choroidal Degenerations, Optic Neuritis, Other Background Retinopathy and Retinal Vascular Changes, Other Corneal Deformities, Cloudy Cornea, Other Retinal Disorders, Prior Penetrating Keratoplasty, Other and Unspecified forms of Chorioretinitis and Retinochoroiditis, Amblyopia, Corneal Edema, Nystagmus and other Irregular Eye Movements, Moderate or Severe Impairment, Better Eye, Profound Impairment Lesser Eye, Hereditary Choroidal Dystrophies, Hereditary Retinal Dystrophies, Burn Confined to Eye and Adnexa, Scleritis and Episcleritis, Other Disorders of Sclera, Focal Chorioretinitis and Focal Retinochoroiditis, Degenerative Disorders of Globe, Degeneration of Macula and Posterior Pole, Disseminated Chorioretinitis and Disseminated Retinochoroiditis, Diabetic Macular Edema, Uveitis, Profound Impairment, Both Eyes, Other Proliferative Retinopathy, Cataract Secondary to Ocular Disorders, Disorders of Visual Cortex, Choroidal Detachment, Disorders of Optic Chiasm, Injury to Optic Nerve and Pathways, Choroidal Hemorrhage and Rupture, Other Disorders of Optic Nerve, Glaucoma, Chorioretinal Scars, Hereditary Corneal Dystrophies, Central Corneal Ulcer, Corneal Opacity and other Disorders of Cornea, Optic Atrophy, Open Wound of Eyeball, Other Endophthalmitis, Separation of Retinal Layers, Diabetic Retinopathy, Visual Field Defects

2017 Clinical Quality Measures January 13, 2017 �6

Page 7: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

• “Visual acuity of 20/40 or better” is an encounter where the VA of OU, OD, or OS is 20/40 or better in any of the following tests:

• Final Refraction with Prism • Refraction - Distance • Refraction - Nearpoint• Technical Refraction• Aided Visual Acuity• Uncorrected Visual Acuity

Per CMS guidance: “This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure.”

To account for this, RevolutionEHR will only score the measure for the provider appearing in the patient’s Demographics if he/she is also the provider listed as the surgeon in the Surgery History component. This will prevent the measure from being scored for ODs.

2017 Clinical Quality Measures January 13, 2017 �7

Page 8: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures (NQF0564 / CMS132v5)

Denominator: All patients aged 18 years and older who had cataract surgery during the reporting period as documented in the Surgery History component and no significant ocular conditions impacting the surgical complication rate.

• Patients with any one of a specified list of significant ocular conditions that impact the surgical complication rate are excluded.

Numerator: Patients who had one or more specified operative procedures for any of the following major complications within 30 days following cataract surgery: retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscence

Notes

• A lower score indicates better quality

• “Cataract surgery” is a surgery with SNOMED code from Appendix D

• “Retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscence” refer to surgeries with SNOMED code:

2536007, 30246007, 4143006, 416773006, 49789002, 438601000, 76240002, 231751005, 231752003, 312705004, 312706003, 312707007, 312714009, 46562009, 65812008, 9137006, 31222007, 36783002, 40395007, 49181006, 13767004, 172426003, 172498005, 172548007, 18752000, 20647004, 21491001, 223217009, 224227005, 225184003, 287233001, 287236009, 287242008, 30113009, 31530007, 35552007, 360405005, 360411008, 363726008, 37332006, 37958004, 417297006, 430833007, 43908008, 444600006, 445023004, 445024005, 4503005, 45817009, 48933009, 50737005, 51281007, 53570002, 54085006, 54211003, 54362002, 5671007, 58689006, 61220009, 64340000, 66134002, 67546003, 72199008, 74948004, 75734004, 78191003, 78290008, 78362007, 84016007, 84542000, 85145001, 8813000, 89788006, 89942008, 90997007, 9255007, 10006000, 12651006, 14707009, 172451002, 172574001, 22768003, 3938007, 4344007, 47470009, 57103007, 68999001, 77950003, 78917001, 85231002, 8920006, 120119003, 12868007, 231741009, 10807008, 84077007, 231780001, 296867007, 3499006, 48671003

• Measure is scored based on the provider appearing in the patient’s demographics

2017 Clinical Quality Measures January 13, 2017 �8

Page 9: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

• “Significant ocular conditions impacting the surgical complication rate” include occurrences of the following:

• Surgery with SNOMED code 87021001 (Mechanical vitrectomy by pars plana approach) prior to cataract surgery

• Medication Rx written prior to surgical date and active on day of surgery:

• Diagnoses made prior to and still active on day of surgery:

Acute and Subacute Iridocyclitis, Adhesions and Disruptions of Iris and Ciliary Body, Central Corneal Ulcer, Burn Confined to Eye and Adnexa, Pseudoexfoliation Syndrome, Senile Cataract, Hypotony of Eye, Cataract Secondary to Ocular Disorders, High Hyperopia, Injury to Optic Nerve and Pathways, Cataract (congenital), Cysts of Iris, Ciliary Body, and Anterior Chamber, Glaucoma, Cataract, Mature or Hypermature, Traumatic Cataract, Cataract, Posterior Polar, Pathologic Myopia, Open Wound of Eyeball, Certain Types of Iridocyclitis, Vascular Disorders of Iris and Ciliary Body, Hereditary Corneal Dystrophies, Enophthalmos, Uveitis, Chronic Iridocyclitis, Corneal Opacity and other Disorders of

2017 Clinical Quality Measures January 13, 2017 �9

RxNORM Code

Description

1100691 {30 (Prazosin 5 MG Oral Capsule) } Pack

197625 Doxazosin 1 MG Oral Tablet

197626 Doxazosin 2 MG Oral Tablet

197627 Doxazosin 4 MG Oral Tablet

197628 Doxazosin 8 MG Oral Tablet

198141 Prazosin 5 MG Oral Capsule

199799 Prazosin 5 MG Oral Tablet

260376 Terazosin 10 MG Oral Capsule

312481 Polythiazide 0.5 MG / Prazosin 1 MG Oral Capsule

312482 Polythiazide 0.5 MG / Prazosin 2 MG Oral Capsule

312483 Polythiazide 0.5 MG / Prazosin 5 MG Oral Capsule

312593 Prazosin 1 MG Oral Capsule

312594 Prazosin 2 MG Oral Capsule

313215 Terazosin 1 MG Oral Capsule

313217 Terazosin 2 MG Oral Capsule

313219 Terazosin 5 MG Oral Capsule

636360 24 HR Doxazosin 4 MG Extended Release Oral Tablet

636361 24 HR Doxazosin 8 MG Extended Release Oral Tablet

861132 24 HR Alfuzosin hydrochloride 10 MG Extended Release Oral Tablet

861402 Phenoxybenzamine Hydrochloride 10 MG Oral Capsule

863669 Tamsulosin hydrochloride 0.4 MG Oral Capsule

996097 Dutasteride 0.5 MG / Tamsulosin hydrochloride 0.4 MG Oral Capsule

Page 10: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Cornea, Cloudy Cornea, Posterior Lenticonus, Aphakia and other Disorders of Lens, Corneal Edema, Retrolental Fibroplasias, Anomalies of Pupillary Function.

Per CMS guidance: “This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure.”

To account for this, RevolutionEHR will only score the measure for the provider appearing in the patient’s Demographics if he/she is also the provider listed as the surgeon in the Surgery History component. This will prevent the measure from being scored for ODs.

2017 Clinical Quality Measures January 13, 2017 �10

Page 11: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

POAG: Optic Nerve Evaluation (NQF0086 / CMS143v5)

Denominator: All patients aged 18 years and older with an active diagnosis of primary open-angle glaucoma and one or more office visits during the reporting period.

• An exception is available when a medical reason is provided for not performing an optic nerve head evaluation.

Numerator: Patients who have an optic nerve head evaluation during one or more office visits within the reporting period

Notes

• “Office visit” is an encounter with at least one service with CPT code: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99241, 99242, 99243, 99244, 99245, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 92002, 92004, 92012, 92014

• “Optic nerve evaluation” requires use of the Optic Nerve test to document each of the following:• “Vert C/D” for at least one eye• “NR Rim”, “Color”, and “Margins” for at least one eye

• Included primary open-angle glaucoma ICD-10 codes: see Appendix E

• Allowed clinical exception SNOMED codes: see Appendix H

2017 Clinical Quality Measures January 13, 2017 �11

Page 12: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Diabetic Retinopathy: Macular Edema and Severity (NQF0088 / CMS167v5)

Denominator: All patients aged 18 years and older with an active diagnosis of diabetic retinopathy and an office visit during reporting period.

• An exception is available when a medical or patient reason is provided for not performing a dilated macular or fundus examination.

Numerator: Patients who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy AND the presence or absence of macular edema during one or more office visits within the reporting period.

Notes

• “Office visit” is an encounter with at least one service with CPT code: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99241, 99242, 99243, 99244, 99245, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 92002, 92004, 92012, 92014

• “Dilated macular or fundus exam performed” requires use of the Fundus test to document each of the following:• “Diab Ret Grd” for at least one eye (cannot be “None”)• “DME Y/N” for at least one eye

• Included diabetic retinopathy ICD-10 codes: see Appendix F

• Allowed clinical exception SNOMED codes: see Appendix G and H

2017 Clinical Quality Measures January 13, 2017 �12

Page 13: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Diabetic Retinopathy: Communication with Physician Managing Diabetes Care (NQF0089 / CMS142v5)

Denominator: All patients aged 18 years and older with an active diagnosis of diabetic retinopathy who had an office visit and dilated macular or fundus exam performed during the reporting period.

• An exception is available when a medical or patient reason is documented for not communicating the findings of the dilated macular or fundus exam to the physician who manages the ongoing care of the patient with diabetes 

Numerator: Patients with documentation, at least once within the reporting period, of the findings of the dilated macular or fundus exam via communication to the physician who manages the patient's diabetic care.

Notes

• “Office visit” is an encounter with at least one service with CPT code: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99241, 99242, 99243, 99244, 99245, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 92002, 92004, 92012, 92014

• “Dilated macular or fundus exam performed” requires use of the Fundus test to document each of the following:• “Diab Ret Grd” for at least one eye (cannot be “None”)• “DME Y/N” for at least one eye

2017 Clinical Quality Measures January 13, 2017 �13

Page 14: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

• “Communication” requires printing/saving an exam letter:• With template “Diabetes Encounter Summary for PCP”, “Vision Source Diabetes and Glaucoma

Encounter Summary for PCP” or “Vision Source Diabetes Encounter Summary for PCP”• Whose recipient is a Provider or External Provider

• Included diabetic retinopathy ICD-10 codes: see Appendix F

• Allowed clinical exception SNOMED codes: see Appendix G and H

2017 Clinical Quality Measures January 13, 2017 �14

Page 15: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix A: ICD-10 Codes for Diabetes

ICD-10 Description

E10.10 Type 1 diabetes mellitus with ketoacidosis without coma

E10.11 Type 1 diabetes mellitus with ketoacidosis with coma

E10.21 Type 1 diabetes mellitus with diabetic nephropathy

E10.22 Type 1 diabetes mellitus with diabetic chronic kidney disease

E10.29 Type 1 diabetes mellitus with other diabetic kidney complication

E10.311 Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema

E10.319 Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema

E10.321 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema

E10.3211 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye

E10.3212 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye

E10.3213 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E10.3219 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E10.329 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema

E10.3291 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye

E10.3292 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye

E10.3293 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E10.3299 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E10.331 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema

E10.3311 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E10.3312 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E10.3313 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

E10.3319 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E10.339 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

E10.3391 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E10.3392 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

E10.3393 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E10.3399 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

E10.341 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema

E10.3411 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye

ICD-10

2017 Clinical Quality Measures January 13, 2017 �15

Page 16: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E10.3412 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

E10.3413 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E10.3419 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E10.349 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

E10.3491 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

E10.3492 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

E10.3493 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E10.3499 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

E10.351 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema

E10.3511 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye

E10.3512 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye

E10.3513 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral

E10.3519 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

E10.3521 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E10.3522 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E10.3523 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E10.3529 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E10.3531 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E10.3532 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E10.3533 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

E10.3539 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E10.3541 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

E10.3542 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E10.3543 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

E10.3549 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E10.3551 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, right eye

E10.3552 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, left eye

E10.3553 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

E10.3559 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

E10.359 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema

E10.3591 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

E10.3592 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

E10.3593 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �16

Page 17: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E10.3599 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

E10.36 Type 1 diabetes mellitus with diabetic cataract

E10.37X1 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye

E10.37X2 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye

E10.37X3 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral

E10.37X9 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye

E10.39 Type 1 diabetes mellitus with other diabetic ophthalmic complication

E10.40 Type 1 diabetes mellitus with diabetic neuropathy, unspecified

E10.41 Type 1 diabetes mellitus with diabetic mononeuropathy

E10.42 Type 1 diabetes mellitus with diabetic polyneuropathy

E10.43 Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy

E10.44 Type 1 diabetes mellitus with diabetic amyotrophy

E10.49 Type 1 diabetes mellitus with other diabetic neurological complication

E10.51 Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene

E10.52 Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene

E10.59 Type 1 diabetes mellitus with other circulatory complications

E10.610 Type 1 diabetes mellitus with diabetic neuropathic arthropathy

E10.618 Type 1 diabetes mellitus with other diabetic arthropathy

E10.620 Type 1 diabetes mellitus with diabetic dermatitis

E10.621 Type 1 diabetes mellitus with foot ulcer

E10.622 Type 1 diabetes mellitus with other skin ulcer

E10.628 Type 1 diabetes mellitus with other skin complications

E10.630 Type 1 diabetes mellitus with periodontal disease

E10.638 Type 1 diabetes mellitus with other oral complications

E10.641 Type 1 diabetes mellitus with hypoglycemia with coma

E10.649 Type 1 diabetes mellitus with hypoglycemia without coma

E10.65 Type 1 diabetes mellitus with hyperglycemia

E10.69 Type 1 diabetes mellitus with other specified complication

E10.8 Type 1 diabetes mellitus with unspecified complications

E10.9 Type 1 diabetes mellitus without complications

E11.00 Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)

E11.01 Type 2 diabetes mellitus with hyperosmolarity with coma

E11.21 Type 2 diabetes mellitus with diabetic nephropathy

E11.22 Type 2 diabetes mellitus with diabetic chronic kidney disease

E11.29 Type 2 diabetes mellitus with other diabetic kidney complication

E11.311 Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema

E11.319 Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �17

Page 18: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E11.321 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema

E11.3211 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye

E11.3212 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye

E11.3213 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E11.3219 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E11.329 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema

E11.3291 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye

E11.3292 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye

E11.3293 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E11.3299 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E11.331 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema

E11.3311 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E11.3312 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E11.3313 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

E11.3319 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E11.339 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

E11.3391 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E11.3392 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

E11.3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E11.3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

E11.341 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema

E11.3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye

E11.3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

E11.3413 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E11.3419 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E11.349 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

E11.3491 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

E11.3492 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

E11.3493 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E11.3499 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �18

Page 19: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E11.351 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema

E11.3511 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye

E11.3512 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye

E11.3513 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral

E11.3519 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

E11.3521 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E11.3522 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E11.3523 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E11.3529 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E11.3531 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E11.3532 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E11.3533 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

E11.3539 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E11.3541 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

E11.3542 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E11.3543 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

E11.3549 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E11.3551 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye

E11.3552 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye

E11.3553 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

E11.3559 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

E11.359 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema

E11.3591 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

E11.3592 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

E11.3593 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral

E11.3599 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

E11.36 Type 2 diabetes mellitus with diabetic cataract

E11.37X1 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye

E11.37X2 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye

E11.37X3 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral

E11.37X9 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye

E11.39 Type 2 diabetes mellitus with other diabetic ophthalmic complication

E11.40 Type 2 diabetes mellitus with diabetic neuropathy, unspecified

E11.41 Type 2 diabetes mellitus with diabetic mononeuropathy

E11.42 Type 2 diabetes mellitus with diabetic polyneuropathy

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �19

Page 20: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E11.43 Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy

E11.44 Type 2 diabetes mellitus with diabetic amyotrophy

E11.49 Type 2 diabetes mellitus with other diabetic neurological complication

E11.51 Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene

E11.52 Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene

E11.59 Type 2 diabetes mellitus with other circulatory complications

E11.610 Type 2 diabetes mellitus with diabetic neuropathic arthropathy

E11.618 Type 2 diabetes mellitus with other diabetic arthropathy

E11.620 Type 2 diabetes mellitus with diabetic dermatitis

E11.621 Type 2 diabetes mellitus with foot ulcer

E11.622 Type 2 diabetes mellitus with other skin ulcer

E11.628 Type 2 diabetes mellitus with other skin complications

E11.630 Type 2 diabetes mellitus with periodontal disease

E11.638 Type 2 diabetes mellitus with other oral complications

E11.641 Type 2 diabetes mellitus with hypoglycemia with coma

E11.649 Type 2 diabetes mellitus with hypoglycemia without coma

E11.65 Type 2 diabetes mellitus with hyperglycemia

E11.69 Type 2 diabetes mellitus with other specified complication

E11.8 Type 2 diabetes mellitus with unspecified complications

E11.9 Type 2 diabetes mellitus without complications

E13.00 Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)

E13.01 Other specified diabetes mellitus with hyperosmolarity with coma

E13.10 Other specified diabetes mellitus with ketoacidosis without coma

E13.11 Other specified diabetes mellitus with ketoacidosis with coma

E13.21 Other specified diabetes mellitus with diabetic nephropathy

E13.22 Other specified diabetes mellitus with diabetic chronic kidney disease

E13.29 Other specified diabetes mellitus with other diabetic kidney complication

E13.311 Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema

E13.319 Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema

E13.321 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �20

Page 21: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E13.3211 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye

E13.3212 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye

E13.3213 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E13.3219 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E13.329 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema

E13.3291 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye

E13.3292 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye

E13.3293 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E13.3299 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E13.331 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema

E13.3311 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E13.3312 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E13.3313 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

E13.3319 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E13.339 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

E13.3391 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E13.3392 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

E13.3393 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E13.3399 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

E13.341 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema

E13.3411 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye

E13.3412 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

E13.3413 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E13.3419 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E13.349 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

E13.3491 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

E13.3492 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

E13.3493 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E13.3499 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

E13.351 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �21

Page 22: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E13.3511 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye

E13.3512 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye

E13.3513 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral

E13.3519 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

E13.3521 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E13.3522 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E13.3523 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E13.3529 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E13.3531 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E13.3532 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E13.3533 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

E13.3539 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E13.3541 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

E13.3542 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E13.3543 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

E13.3549 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E13.3551 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, right eye

E13.3552 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, left eye

E13.3553 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

E13.3559 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

E13.359 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema

E13.3591 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

E13.3592 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

E13.3593 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral

E13.3599 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

E13.36 Other specified diabetes mellitus with diabetic cataract

E13.37X1 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, right eye

E13.37X2 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, left eye

E13.37X3 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral

E13.37X9 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye

E13.39 Other specified diabetes mellitus with other diabetic ophthalmic complication

E13.40 Other specified diabetes mellitus with diabetic neuropathy, unspecified

E13.41 Other specified diabetes mellitus with diabetic mononeuropathy

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �22

Page 23: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E13.42 Other specified diabetes mellitus with diabetic polyneuropathy

E13.43 Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy

E13.44 Other specified diabetes mellitus with diabetic amyotrophy

E13.49 Other specified diabetes mellitus with other diabetic neurological complication

E13.51 Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene

E13.52 Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene

E13.59 Other specified diabetes mellitus with other circulatory complications

E13.610 Other specified diabetes mellitus with diabetic neuropathic arthropathy

E13.618 Other specified diabetes mellitus with other diabetic arthropathy

E13.620 Other specified diabetes mellitus with diabetic dermatitis

E13.621 Other specified diabetes mellitus with foot ulcer

E13.622 Other specified diabetes mellitus with other skin ulcer

E13.628 Other specified diabetes mellitus with other skin complications

E13.630 Other specified diabetes mellitus with periodontal disease

E13.638 Other specified diabetes mellitus with other oral complications

E13.641 Other specified diabetes mellitus with hypoglycemia with coma

E13.649 Other specified diabetes mellitus with hypoglycemia without coma

E13.65 Other specified diabetes mellitus with hyperglycemia

E13.69 Other specified diabetes mellitus with other specified complication

E13.8 Other specified diabetes mellitus with unspecified complications

E13.9 Other specified diabetes mellitus without complications

O24.011 Pre-existing type 1 diabetes mellitus, in pregnancy, first trimester

O24.012 Pre-existing type 1 diabetes mellitus, in pregnancy, second trimester

O24.013 Pre-existing type 1 diabetes mellitus, in pregnancy, third trimester

O24.019 Pre-existing type 1 diabetes mellitus, in pregnancy, unspecified trimester

O24.02 Pre-existing type 1 diabetes mellitus, in childbirth

O24.03 Pre-existing type 1 diabetes mellitus, in the puerperium

O24.111 Pre-existing type 2 diabetes mellitus, in pregnancy, first trimester

O24.112 Pre-existing type 2 diabetes mellitus, in pregnancy, second trimester

O24.113 Pre-existing type 2 diabetes mellitus, in pregnancy, third trimester

O24.119 Pre-existing type 2 diabetes mellitus, in pregnancy, unspecified trimester

O24.12 Pre-existing type 2 diabetes mellitus, in childbirth

O24.13 Pre-existing type 2 diabetes mellitus, in the puerperium

O24.311 Unspecified pre-existing diabetes mellitus in pregnancy, first trimester

O24.312 Unspecified pre-existing diabetes mellitus in pregnancy, second trimester

O24.313 Unspecified pre-existing diabetes mellitus in pregnancy, third trimester

O24.319 Unspecified pre-existing diabetes mellitus in pregnancy, unspecified trimester

O24.32 Unspecified pre-existing diabetes mellitus in childbirth

O24.33 Unspecified pre-existing diabetes mellitus in the puerperium

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �23

Page 24: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

O24.811 Other pre-existing diabetes mellitus in pregnancy, first trimester

O24.812 Other pre-existing diabetes mellitus in pregnancy, second trimester

O24.813 Other pre-existing diabetes mellitus in pregnancy, third trimester

O24.819 Other pre-existing diabetes mellitus in pregnancy, unspecified trimester

O24.82 Other pre-existing diabetes mellitus in childbirth

O24.83 Other pre-existing diabetes mellitus in the puerperium

DescriptionICD-10

2017 Clinical Quality Measures January 13, 2017 �24

Page 25: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix B: High-Risk Medications for the Elderly

RxNORM Code Description

1000351 Estrogens, Conjugated (USP) 0.3 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet1000352 Estrogens, Conjugated (USP) 0.45 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet1000355 Estrogens, Conjugated (USP) 0.625 MG / medroxyprogesterone acetate 2.5 MG Oral Tablet1000356 Estrogens, Conjugated (USP) 0.625 MG / medroxyprogesterone acetate 5 MG Oral Tablet

1000395 {28 (Estrogens, Conjugated (USP) 0.625 MG / medroxyprogesterone acetate 2.5 MG Oral Tablet) } Pack

1000398 {28 (Estrogens, Conjugated (USP) 0.625 MG / medroxyprogesterone acetate 5 MG Oral Tablet) } Pack

1000486 {14 (Estrogens, Conjugated (USP) 0.625 MG / medroxyprogesterone acetate 5 MG Oral Tablet) / 14 (Estrogens, Conjugated (USP) 0.625 MG Oral Tablet) } Pack

1000490 {28 (Estrogens, Conjugated (USP) 0.3 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet) } Pack

1000496 {28 (Estrogens, Conjugated (USP) 0.45 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet) } Pack

1010696 Carbinoxamine maleate 0.8 MG/ML Oral Solution

1010946 Carbinoxamine maleate 0.8 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML / Pseudoephedrine Hydrochloride 12 MG/ML Oral Solution

1012764 Carbinoxamine maleate 8 MG / Phenylephrine Hydrochloride 40 MG Extended Release Oral Tablet

1012904 Carbinoxamine maleate 4 MG Oral Tablet1012950 Carbinoxamine Tannate 0.4 MG/ML Oral Suspension1012972 Carbinoxamine Tannate 0.64 MG/ML Oral Suspension

1012980 Carbinoxamine Tannate 0.72 MG/ML / PSEUDOEPHEDRINE TANNATE 9.04 MG/ML Extended Release Suspension

1012982 Carbinoxamine Tannate 0.72 MG/ML Extended Release Suspension1012995 Carbinoxamine maleate 0.334 MG/ML Oral Solution1013611 Chlorpheniramine Maleate 2 MG / Pseudoephedrine Hydrochloride 30 MG Chewable Tablet1013619 Chlorpheniramine Maleate 3 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

1020199 Acetaminophen 163 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1020477 Diphenhydramine Hydrochloride 50 MG Oral Capsule1037364 Brompheniramine Tannate 1 MG/ML / Phenylephrine Tannate 1 MG/ML Oral Suspension1037379 Brompheniramine Tannate 0.8 MG/ML / Phenylephrine Tannate 1 MG/ML Oral Suspension

1038851 Acetaminophen 2.71 MG/ML / Diphenhydramine Hydrochloride 0.104 MG/ML / Phenylephrine Hydrochloride 0.0417 MG/ML Oral Solution

1038876 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Solution

1041814 thyroid (USP) 97.5 MG Oral Tablet

1042684 Acetaminophen 33.3 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution

1042688 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule

1042693 Chlorpheniramine Maleate 0.4 MG/ML / Codeine Phosphate 2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution

1043400 Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution

1046384 Acetaminophen 21.7 MG/ML / Chlorpheniramine Maleate 0.133 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Solution

1046751 Acetaminophen 325 MG / Diphenhydramine Hydrochloride 25 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1046781 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1046799{12 (Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) / 12 (Acetaminophen 325 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) } Pack

1047805 butabarbital 15 MG / Hyoscyamine hydrobromide 0.3 MG / Phenazopyridine hydrochloride 150 MG Oral Tablet

RxNORM Code

2017 Clinical Quality Measures January 13, 2017 �25

Page 26: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

104812412 HR Atropine Sulfate 0.04 MG / Chlorpheniramine Maleate 8 MG / Hyoscyamine Sulfate 0.19 MG / Pseudoephedrine Hydrochloride 90 MG / Scopolamine Hydrobromide 0.01 MG Extended Release Oral Tablet

1049630 Diphenhydramine Hydrochloride 25 MG Oral Tablet1049900 Diphenhydramine Hydrochloride 12.5 MG Chewable Tablet1049904 Diphenhydramine Hydrochloride 12.5 MG Oral Strip1049906 Diphenhydramine Hydrochloride 2.5 MG/ML Oral Solution1049909 Diphenhydramine Hydrochloride 25 MG Oral Capsule1049918 Diphenhydramine Hydrochloride 25 MG Oral Strip

1050385 Acetaminophen 32 MG/ML / Diphenhydramine Hydrochloride 1.25 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution

1052462 Acetaminophen 325 MG / Diphenhydramine Hydrochloride 12.5 MG Oral Tablet1052467 Acetaminophen 500 MG / Diphenhydramine Hydrochloride 12.5 MG Oral Tablet

1052647 Acetaminophen 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule

1052679 Acetaminophen 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1052928 Diphenhydramine Hydrochloride 25 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

1053618 Chlorpheniramine Maleate 0.4 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1053624 Chlorpheniramine Maleate 1 MG / Pseudoephedrine Hydrochloride 15 MG Chewable Tablet1085945 Diphenhydramine Hydrochloride 50 MG Oral Tablet

1086443 Chlorpheniramine Maleate 0.8 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1086463 Chlorpheniramine Maleate 0.8 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1086475 12 HR Chlorpheniramine Maleate 8 MG / Phenylephrine Hydrochloride 20 MG Extended Release Oral Tablet

1086720 Diphenhydramine Hydrochloride 2.5 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution

1086750 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Suspension

1086991 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1087459 12 HR CHLORPHENIRAMINE POLISTIREX 1.6 MG/ML / HYDROCODONE POLISTIREX 2 MG/ML Extended Release Suspension

1087607 Acetaminophen 500 MG / Diphenhydramine Hydrochloride 50 MG Oral Tablet1088934 Chlorzoxazone 375 MG Oral Tablet1088936 Chlorzoxazone 750 MG Oral Tablet

1089822 Acetaminophen 325 MG / Dextromethorphan Hydrobromide 15 MG / doxylamine succinate 6.25 MG / Pseudoephedrine Hydrochloride 30 MG Oral Capsule

1089917 {12 (Diphenhydramine Hydrochloride 25 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet) / 18 (Phenylephrine Hydrochloride 10 MG Oral Tablet) } Pack

1089968 Acetaminophen 500 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 15 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1090443 Chlorpheniramine Maleate 4 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet1090532 Chlorpheniramine Maleate 1 MG/ML / Phenylephrine Hydrochloride 3.5 MG/ML Oral Solution1090699 Chlorpheniramine Maleate 2 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1092189 Acetaminophen 500 MG / Diphenhydramine Hydrochloride 25 MG Oral Tablet1092373 Acetaminophen 33.3 MG/ML / Diphenhydramine Hydrochloride 1.67 MG/ML Oral Solution1092398 Aspirin 500 MG / Diphenhydramine Hydrochloride 25 MG Oral Tablet

1092566 {7 (24 HR Guanfacine 1 MG Extended Release Oral Tablet) / 7 (24 HR Guanfacine 2 MG Extended Release Oral Tablet) } Pack

1093075 Acetaminophen 325 MG / Diphenhydramine Hydrochloride 50 MG Oral Tablet

1093083 Acetaminophen 650 MG / Diphenhydramine Hydrochloride 50 MG Oral Tablet1093098 Diphenhydramine Hydrochloride 25 MG Disintegrating Oral Tablet

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �26

Page 27: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

1094131 Acetaminophen 65 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML / Diphenhydramine Hydrochloride 2.5 MG/ML Oral Solution

1094330 Brompheniramine Maleate 0.8 MG/ML / Pseudoephedrine Hydrochloride 4 MG/ML Oral Solution

1094350 Dextromethorphan Hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1094355 doxylamine succinate 1.25 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution1094406 chlophedianol hydrochloride 5 MG/ML / Triprolidine Hydrochloride 0.5 MG/ML Oral Solution1094434 Phenylephrine Hydrochloride 2 MG/ML / Triprolidine Hydrochloride 0.5 MG/ML Oral Solution

1094501 chlophedianol hydrochloride 5 MG/ML / Phenylephrine Hydrochloride 2 MG/ML / Triprolidine Hydrochloride 0.5 MG/ML Oral Solution

1094549 Acetaminophen 325 MG / Dextromethorphan Hydrobromide 15 MG / doxylamine succinate 6.25 MG Oral Capsule

1098443

{10 (Acetaminophen 325 MG / Dextromethorphan Hydrobromide 10 MG / Guaifenesin 100 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) / 10 (Acetaminophen 325 MG / Diphenhydramine Hydrochloride 25 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) } Pack

1098496 Acetaminophen 500 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 15 MG Oral Tablet

1098498 Brompheniramine Maleate 0.2 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution

1099308 Pseudoephedrine Hydrochloride 6 MG/ML / Triprolidine Hydrochloride 0.25 MG/ML Oral Solution

1099446 Pseudoephedrine Hydrochloride 60 MG / Triprolidine Hydrochloride 2.5 MG Oral Tablet

1099653 Dextromethorphan Hydrobromide 4 MG/ML / Pseudoephedrine Hydrochloride 10 MG/ML / Triprolidine Hydrochloride 0.938 MG/ML Oral Suspension

1099659 Phenylephrine Hydrochloride 10 MG / Triprolidine Hydrochloride 2.5 MG Oral Tablet

1099668 Pseudoephedrine Hydrochloride 10 MG/ML / Triprolidine Hydrochloride 0.938 MG/ML Oral Solution

1099677 Pseudoephedrine Hydrochloride 9 MG/ML / Triprolidine Hydrochloride 0.25 MG/ML Oral Solution

1099684 Triprolidine Hydrochloride 0.25 MG/ML Oral Solution

1099711 Codeine Phosphate 20 MG / Pseudoephedrine Hydrochloride 60 MG / Triprolidine Hydrochloride 4 MG Oral Tablet

1099779 PSEUDOEPHEDRINE TANNATE 9 MG/ML / triprolidine tannate 0.5 MG/ML Extended Release Suspension

1099788 triprolidine tannate 0.5 MG/ML Extended Release Suspension1099872 Acetaminophen 500 MG / Diphenhydramine Citrate 38 MG Oral Tablet1099948 thyroid (USP) 48.75 MG Oral Tablet

1100501 Chlorpheniramine Maleate 0.8 MG/ML / Phenylephrine Hydrochloride 2.5 MG/ML Oral Solution

1101427 doxylamine succinate 1 MG/ML Oral Suspension1101439 doxylamine succinate 5 MG Chewable Tablet1101446 doxylamine succinate 25 MG Oral Tablet

1101457 doxylamine succinate 1 MG/ML Oral Solution

1101555{12 (Acetaminophen 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) / 16 (Acetaminophen 500 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) } Pack

1101741 12 HR Chlorpheniramine Maleate 8 MG / methscopolamine nitrate 2.5 MG / Phenylephrine Hydrochloride 20 MG Extended Release Oral Tablet

1101855 12 HR Chlorpheniramine Maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet

1111171 12 HR Belladonna Alkaloids 0.24 MG / Chlorpheniramine Maleate 8 MG / Pseudoephedrine Hydrochloride 90 MG Extended Release Oral Tablet

1111440 Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1.5 MG/ML Oral Solution

1112220 Chlorpheniramine Maleate 0.8 MG/ML / Hydrocodone Bitartrate 1 MG/ML / Pseudoephedrine Hydrochloride 12 MG/ML Oral Solution

1112489 Chlorpheniramine Maleate 1 MG/ML / Phenylephrine Hydrochloride 2.5 MG/ML Oral Solution

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �27

Page 28: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

1112779 12 HR Chlorpheniramine Maleate 8 MG / Pseudoephedrine Hydrochloride 120 MG Extended Release Oral Capsule

1112791 Chlorpheniramine Maleate 1 MG/ML / Dextromethorphan Hydrobromide 2.5 MG/ML / Phenylephrine Hydrochloride 2.5 MG/ML Oral Solution

1112864 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG Oral Tablet

1112906

{10 (Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) / 10 (Acetaminophen 325 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) } Pack

1112908

{12 (Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) / 12 (Acetaminophen 325 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) } Pack

1113380 Chlorpheniramine Maleate 0.8 MG/ML / Pseudoephedrine Hydrochloride 9 MG/ML Oral Solution

1113397 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Suspension

1113417 Chlorpheniramine Maleate 0.4 MG/ML / Codeine Phosphate 2 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1113522 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1.5 MG/ML Oral Solution

1113998 Chlorpheniramine Maleate 0.4 MG/ML / Codeine Phosphate 1.6 MG/ML Oral Solution

1114003 Chlorpheniramine Maleate 0.4 MG/ML / Codeine Phosphate 1.6 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1114361 Chlorpheniramine Maleate 0.133 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Solution

1114838 Chlorpheniramine Maleate 2 MG/ML / Phenylephrine Hydrochloride 5 MG/ML Oral Solution

1115329 Dextromethorphan Hydrobromide 1.5 MG/ML / doxylamine succinate 0.625 MG/ML Oral Solution

1117245 Acetaminophen 500 MG / Diphenhydramine Hydrochloride 25 MG Oral Capsule

1117392 Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution

1125488 Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1147029 Chlorpheniramine Maleate 0.133 MG/ML / Dextromethorphan Hydrobromide 0.667 MG/ML / Guaifenesin 13.3 MG/ML Oral Solution

1147619 Acetaminophen 650 MG / Diphenhydramine Hydrochloride 25 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

1147795 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1148155 Brompheniramine Maleate 0.8 MG/ML / Dextromethorphan Hydrobromide 4 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1149632 84 HR Estradiol 0.00313 MG/HR Transdermal Patch

1188532 chlophedianol hydrochloride 5 MG/ML / Chlorpheniramine Maleate 0.8 MG/ML / Pseudoephedrine Hydrochloride 9 MG/ML Oral Solution

1189337 Cyclobenzaprine hydrochloride 1 MG/ML Oral Suspension

1190174 Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution

1190448 12 HR Diphenhydramine Hydrochloride 100 MG / Pseudoephedrine Hydrochloride 120 MG Extended Release Oral Tablet

1190580 Codeine Phosphate 1.2 MG/ML / Dexbrompheniramine maleate 0.133 MG/ML / Pseudoephedrine Hydrochloride 4 MG/ML Oral Solution

1190600 Dexbrompheniramine maleate 0.133 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML / Pseudoephedrine Hydrochloride 4 MG/ML Oral Solution

1190931 Acetaminophen 650 MG / Dexbrompheniramine maleate 2 MG Oral Tablet1192477 Brompheniramine Maleate 4 MG / Pseudoephedrine Hydrochloride 60 MG Oral Capsule

1193293 Acetaminophen 325 MG / Chlorpheniramine Maleate 4 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �28

Page 29: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

1233546{20 (Acetaminophen 325 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule) / 20 (Acetaminophen 325 MG / Dextromethorphan Hydrobromide 15 MG / doxylamine succinate 6.25 MG Oral Capsule) } Pack

1233575 Acetaminophen 325 MG / Diphenhydramine Hydrochloride 12.5 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1234386 Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution

1234884 Chlorpheniramine Maleate 0.4 MG/ML / dihydrocodeine bitartrate 1.3 MG/ML / Phenylephrine Hydrochloride 0.8 MG/ML Oral Solution

1236048 Diphenhydramine Hydrochloride 1.25 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution

1236395 Acetaminophen 250 MG / Dextromethorphan Hydrobromide 10 MG / doxylamine succinate 6.25 MG / Pseudoephedrine Hydrochloride 30 MG Oral Capsule

12364034.5 ML Acetaminophen 144 MG/ML / Dextromethorphan Hydrobromide 4.44 MG/ML / doxylamine succinate 2.78 MG/ML / Phenylephrine Hydrochloride 2.22 MG/ML Prefilled Applicator

1236428 Acetaminophen 500 MG / doxylamine succinate 6.25 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1236459{12 (Acetaminophen 500 MG / doxylamine succinate 6.25 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet) / 12 (Acetaminophen 500 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet) } Pack

1237110 Acetaminophen 33.3 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML Oral Solution

1237118 12 HR Chlorpheniramine Maleate 4 MG / Pseudoephedrine Hydrochloride 60 MG Extended Release Oral Capsule

1242502 Acetaminophen 33.3 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML / Phenylephrine Hydrochloride 0.333 MG/ML Oral Solution

1242582 doxylamine succinate 25 MG Oral Capsule1242618 Acetaminophen 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet

1244523 Brompheniramine Maleate 1.2 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Suspension

1244714 24 HR Chlorpheniramine Maleate 12 MG / Pseudoephedrine Hydrochloride 100 MG Extended Release Oral Capsule

1244918 Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.25 MG/ML Oral Solution

1244951{10 (Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) / 10 (Acetaminophen 325 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) } Pack

1245284 Chlorpheniramine Maleate 0.8 MG/ML / methscopolamine nitrate 0.25 MG/ML Oral Solution

1245291 Chlorpheniramine Maleate 1 MG / Dextromethorphan Hydrobromide 5 MG / Pseudoephedrine Hydrochloride 15 MG Chewable Tablet

1245298 Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1.5 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution

1245374 {50 (Acetaminophen 500 MG / Diphenhydramine Hydrochloride 25 MG Oral Tablet) / 50 (Acetaminophen 500 MG Oral Tablet) } Pack

1245706 chlophedianol hydrochloride 4.8 MG/ML / Chlorpheniramine Maleate 0.8 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Suspension

1248057 Phenylephrine Hydrochloride 1 MG/ML / Promethazine Hydrochloride 1.25 MG/ML Oral Solution

1248354 Diphenhydramine Hydrochloride 1.67 MG/ML Oral Solution

1248750 chlophedianol hydrochloride 8 MG/ML / Chlorpheniramine Maleate 1.25 MG/ML / Phenylephrine Hydrochloride 2.5 MG/ML Oral Suspension

1249617 Acetaminophen 300 MG / butalbital 50 MG Oral Tablet

1250528 Acetaminophen 4.17 MG/ML / Chlorpheniramine Maleate 0.0167 MG/ML / Dextromethorphan Hydrobromide 0.125 MG/ML / Pseudoephedrine Hydrochloride 0.25 MG/ML Oral Solution

1250751 Chlorpheniramine Maleate 0.4 MG/ML / methscopolamine nitrate 0.125 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1250949 Chlorpheniramine Maleate 0.4 MG/ML / methscopolamine nitrate 0.25 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1251039 Chlorpheniramine Maleate 1 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML / Phenylephrine Hydrochloride 3.5 MG/ML Oral Solution

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �29

Page 30: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

1251185 Chlorpheniramine Maleate 0.8 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML / Phenylephrine Hydrochloride 2.5 MG/ML Oral Solution

1251493 84 HR Estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR Transdermal Patch1251499 84 HR Estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal Patch1251614 Butabarbital sodium 30 MG Oral Tablet1251621 Butabarbital sodium 50 MG Oral Tablet1251770 Diphenhydramine Hydrochloride 3.33 MG/ML Oral Solution

1251776 Diphenhydramine Hydrochloride 12.5 MG / Phenylephrine Hydrochloride 5 MG Oral Strip1251811 Chlorpheniramine Maleate 1 MG / Dextromethorphan Hydrobromide 5 MG Chewable Tablet1251838 Diphenhydramine Hydrochloride 5 MG/ML Oral Suspension

1251928 Acetaminophen 500 MG / Chlorpheniramine Maleate 2 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1291266 Chlorpheniramine Maleate 0.8 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1291711 Acetaminophen 500 MG / Diphenhydramine Hydrochloride 25 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1291718{12 (Acetaminophen 500 MG / Chlorpheniramine Maleate 2 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet) / 12 (Acetaminophen 500 MG / Diphenhydramine Hydrochloride 25 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet) } Pack

1291854 Acetaminophen 650 MG / Diphenhydramine Hydrochloride 50 MG / Pseudoephedrine Hydrochloride 60 MG Oral Tablet

1291868 Aspirin 325 MG / Diphenhydramine Citrate 38 MG Oral Tablet

1292322 Diphenhydramine Hydrochloride 25 MG / Magnesium Salicylate 500 MG Oral Tablet

1292342 Acetaminophen 43.3 MG/ML / Chlorpheniramine Maleate 0.267 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML Oral Solution

1293239 Dexchlorpheniramine maleate 2 MG / Pseudoephedrine Hydrochloride 60 MG Oral Tablet

1293298 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 15 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1293344 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1294201 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Pseudoephedrine Hydrochloride 30 MG Oral Capsule

1294322 Diphenhydramine Hydrochloride 5 MG/ML / Phenylephrine Hydrochloride 1.5 MG/ML Oral Solution

1294348 Diphenhydramine Hydrochloride 12.5 MG / Phenylephrine Hydrochloride 5 MG Chewable Tablet

1294557 Diphenhydramine Hydrochloride 25 MG / Pseudoephedrine Hydrochloride 60 MG Oral Tablet

1294567 Acetaminophen 500 MG / Diphenhydramine Hydrochloride 12.5 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1294594 Diphenhydramine Hydrochloride 2.5 MG/ML / Menthol 4.4 MG/ML Oral Suspension

1294602 Acetaminophen 32 MG/ML / Diphenhydramine Hydrochloride 2.5 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Suspension

1294607 Acetaminophen 21.7 MG/ML / Diphenhydramine Hydrochloride 0.833 MG/ML Oral Solution

1297390 Chlorpheniramine Maleate 2 MG / Ibuprofen 200 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1297517 Diphenhydramine Hydrochloride 25 MG / Magnesium Salicylate 580 MG Oral Tablet1297947 Acetaminophen 500 MG / Diphenhydramine Citrate 38 MG Oral Powder

1297967 12 HR Acetaminophen 575 MG / Dextromethorphan Hydrobromide 30 MG / Diphenhydramine Hydrochloride 37.5 MG / Phenylephrine Hydrochloride 18 MG Extended Release Oral Tablet

1297974 Acetaminophen 575 MG / Dextromethorphan Hydrobromide 20 MG / Diphenhydramine Hydrochloride 37.5 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

1298226 Dexchlorpheniramine maleate 0.2 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1298348 Acetaminophen 21.7 MG/ML / Diphenhydramine Hydrochloride 0.833 MG/ML / Phenylephrine Hydrochloride 0.333 MG/ML Oral Solution

1298433 Dexchlorpheniramine maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1298799 Isoxsuprine Hydrochloride 20 MG Oral Tablet

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �30

Page 31: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

1298834 Isoxsuprine Hydrochloride 10 MG Oral Tablet

1299143 Dexbrompheniramine maleate 0.2 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1299646 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 15 MG / Pseudoephedrine Hydrochloride 30 MG Oral Capsule

1299662 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Pseudoephedrine Hydrochloride 30 MG Oral Capsule

1300084 12 HR Brompheniramine Maleate 12 MG / Pseudoephedrine Hydrochloride 120 MG Extended Release Oral Capsule

1300164 Dexbrompheniramine maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 4 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1300195 Dexbrompheniramine maleate 0.5 MG/ML / Dextromethorphan Hydrobromide 5 MG/ML / Phenylephrine Hydrochloride 2.5 MG/ML Oral Solution

1303797 Dexbrompheniramine maleate 1 MG/ML / Dextromethorphan Hydrobromide 10 MG/ML / Phenylephrine Hydrochloride 5 MG/ML Oral Solution

1304533 Brompheniramine Tannate 1.2 MG/ML / PSEUDOEPHEDRINE TANNATE 6 MG/ML Extended Release Suspension

1307111 Chlorpheniramine Maleate 0.75 MG/ML / Dextromethorphan Hydrobromide 2.75 MG/ML / Phenylephrine Hydrochloride 1.75 MG/ML Oral Solution

1307244 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 15 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1308438 Brompheniramine Maleate 0.4 MG/ML / Codeine Phosphate 2 MG/ML Oral Solution

1308442 Chlorpheniramine Maleate 0.5 MG/ML / Phenylephrine Hydrochloride 1 MG/ML / Phenyltoloxamine citrate 1.5 MG/ML Oral Solution

1310503 Chlorpheniramine Maleate 4 MG / Ibuprofen 200 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

1310627 Chlorpheniramine Maleate 0.8 MG/ML / Dextromethorphan Hydrobromide 2.5 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1313969 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule

1356113{10 (Acetaminophen 325 MG / Diphenhydramine Hydrochloride 25 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) / 10 (Acetaminophen 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet) } Pack

1356800 Brompheniramine Maleate 4 MG / Codeine Phosphate 10 MG Oral Tablet1356807 Brompheniramine Maleate 4 MG / Codeine Phosphate 20 MG Oral Tablet1356841 Brompheniramine Maleate 0.8 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution

1356848 Brompheniramine Tannate 12 MG Chewable Tablet

1356859 Brompheniramine Tannate 2.4 MG/ML / Phenylephrine Tannate 2 MG/ML Extended Release Suspension

1356866 Brompheniramine Maleate 4 MG / Pseudoephedrine Hydrochloride 40 MG Oral Tablet1357013 Brompheniramine Maleate 0.4 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution1357389 Brompheniramine Maleate 0.4 MG/ML Oral Solution

1357553 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution

1357894 12 HR Chlorpheniramine Maleate 8 MG / Dextromethorphan Hydrobromide 30 MG / Phenylephrine Hydrochloride 20 MG Extended Release Oral Tablet

1358753 Chlorpheniramine Maleate 0.4 MG/ML / Hydrocodone Bitartrate 0.5 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1359114 Chlorpheniramine Maleate 4 MG / Dextromethorphan Hydrobromide 20 MG / Pseudoephedrine Hydrochloride 60 MG Oral Tablet

1359123 Estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet1359124 {28 (Estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack1359126 Estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet1359127 {28 (Estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack1363288 12 HR Chlorpheniramine Maleate 12 MG Extended Release Oral Tablet

1363306 Chlorpheniramine Maleate 0.4 MG/ML Oral Solution1363309 Chlorpheniramine Maleate 4 MG Oral Tablet

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �31

Page 32: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

1363513 Dexbrompheniramine maleate 2 MG / Pseudoephedrine Hydrochloride 60 MG Oral Tablet

1363651 Chlorpheniramine Maleate 2 MG / methscopolamine nitrate 1.25 MG / Phenylephrine Hydrochloride 15 MG Chewable Tablet

1363752 Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution

1364278 12 HR Chlorpheniramine Maleate 8 MG / methscopolamine nitrate 2.5 MG / Phenylephrine Hydrochloride 20 MG Extended Release Oral Capsule

1366822 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution

1366825 Acetaminophen 80 MG / Chlorpheniramine Maleate 0.5 MG / Dextromethorphan Hydrobromide 2.5 MG / Pseudoephedrine Hydrochloride 7.5 MG Chewable Tablet

1367203 Acetaminophen 162 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1367219 Brompheniramine Tannate 2.2 MG / Phenylephrine Tannate 1.58 MG Chewable Tablet

1367225 Chlorpheniramine Maleate 2 MG / Guaifenesin 100 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

1367227 Chlorpheniramine Maleate 3.5 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

1368963 chlophedianol hydrochloride 25 MG / Chlorpheniramine Maleate 4 MG / Phenylephrine Hydrochloride 15 MG Oral Tablet

1369403 chlophedianol hydrochloride 2.5 MG/ML / Dexbrompheniramine maleate 0.2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution

1369424 chlophedianol hydrochloride 2.5 MG/ML / Dexchlorpheniramine maleate 0.2 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1369848 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Suspension

1369910 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Suspension

1369971 chlophedianol hydrochloride 6.25 MG/ML / Dexchlorpheniramine maleate 0.5 MG/ML / Pseudoephedrine Hydrochloride 15 MG/ML Oral Solution

1369972 chlophedianol hydrochloride 5 MG/ML / Dexchlorpheniramine maleate 0.4 MG/ML / Pseudoephedrine Hydrochloride 12 MG/ML Oral Solution

1370116 Acetaminophen 33.3 MG/ML / Chlorpheniramine Maleate 0.267 MG/ML / Dextromethorphan Hydrobromide 1.33 MG/ML / Pseudoephedrine Hydrochloride 4 MG/ML Oral Solution

1370122 Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution

1370125 Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 3 MG/ML Oral Solution

1372265 Chlorpheniramine Maleate 0.8 MG/ML / Hydrocodone Bitartrate 1 MG/ML Oral Solution

1372312 Acetaminophen 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Suspension

1374770 12 HR Carbinoxamine maleate 0.8 MG/ML Extended Release Suspension

1375932 Acetaminophen 32.5 MG/ML / Diphenhydramine Hydrochloride 1.25 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution

1421985 Chlorpheniramine Maleate 4 MG / Dextromethorphan Hydrobromide 30 MG Oral Tablet

1422884 Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML Oral Solution

1423711 Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1424295 Acetaminophen 325 MG / Chlorpheniramine Maleate 2 MG / Codeine Phosphate 8 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet

1424850

{1 (180 ML) (Acetaminophen 32.5 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Guaifenesin 20 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution) / 1 (180 ML) (Acetaminophen 32.5 MG/ML / Diphenhydramine Hydrochloride 1.25 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution) } Pack

1424872 chlophedianol hydrochloride 24 MG / Chlorpheniramine Maleate 3.5 MG / Phenylephrine Hydrochloride 10 MG Oral Tablet

1429345 Chlorpheniramine Maleate 0.2 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution

1430148 Acetaminophen 500 MG / Chlorpheniramine Maleate 2 MG / Pseudoephedrine Hydrochloride 30 MG Oral Capsule

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �32

Page 33: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

1430522 12 HR Brompheniramine Maleate 6 MG / Pseudoephedrine Hydrochloride 45 MG Extended Release Oral Tablet

1431286 Acetaminophen 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule

1440003 Codeine Phosphate 1.8 MG/ML / Dexchlorpheniramine maleate 0.2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution

1441376 chlophedianol hydrochloride 2.5 MG/ML / Dexbrompheniramine maleate 0.2 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML Oral Solution

1441392 bazedoxifene 20 MG / Estrogens, Conjugated (USP) 0.45 MG Oral Tablet

1483549 drospirenone 0.25 MG / Estradiol 0.5 MG Oral Tablet1483552 drospirenone 0.5 MG / Estradiol 1 MG Oral Tablet1483553 {28 (drospirenone 0.5 MG / Estradiol 1 MG Oral Tablet) } Pack153444 Estradiol 0.001 MG/MG Topical Gel1546700 Acetaminophen 325 MG / Dexbrompheniramine maleate 1 MG Oral Tablet1724446 Acetaminophen 325 MG / butalbital 25 MG Oral Tablet197426 Acetaminophen 325 MG / butalbital 50 MG Oral Tablet197427 Acetaminophen 650 MG / butalbital 50 MG Oral Capsule197428 Acetaminophen 650 MG / butalbital 50 MG Oral Tablet197446 Carisoprodol 350 MG Oral Tablet

197447 Aspirin 325 MG / Carisoprodol 200 MG Oral Tablet197495 Chlorpropamide 100 MG Oral Tablet

197496 Chlorpropamide 250 MG Oral Tablet

197502 Chlorzoxazone 500 MG Oral Tablet

197622 Dipyridamole 50 MG Oral Tablet197647 ergoloid mesylates, USP 1 MG Oral Capsule197657 Estradiol 0.5 MG Oral Tablet197658 Estradiol 1 MG Oral Tablet197659 Estradiol 2 MG Oral Tablet197660 Estrogens, Conjugated (USP) 0.3 MG Oral Tablet197661 Estrogens, Conjugated (USP) 0.9 MG Oral Tablet197662 Estrogens, Conjugated (USP) 1.25 MG Oral Tablet197663 Estrogens, Conjugated (USP) 2.5 MG Oral Tablet197666 Estrogens, Esterified (USP) 0.3 MG Oral Tablet197667 Estrogens, Esterified (USP) 0.625 MG Oral Tablet

197668 Estrogens, Esterified (USP) 1.25 MG Oral Tablet

197669 Estrogens, Esterified (USP) 2.5 MG Oral Tablet

197670 Estrogens, Esterified (USP) 1.25 MG / Methyltestosterone 2.5 MG Oral Tablet197737 Glyburide 1.25 MG Oral Tablet197745 Guanfacine 1 MG Oral Tablet197746 Guanfacine 2 MG Oral Tablet197817 Indomethacin 25 MG Oral Capsule197818 Indomethacin 50 MG Oral Capsule197819 Indomethacin 50 MG Rectal Suppository197923 Mephobarbital 100 MG Oral Tablet197924 Mephobarbital 32 MG Oral Tablet197925 Mephobarbital 50 MG Oral Tablet197928 Meprobamate 200 MG Oral Tablet197929 Meprobamate 400 MG Oral Tablet197930 Aspirin 325 MG / Meprobamate 200 MG Oral Tablet197935 metaxalone 400 MG Oral Tablet197943 Methocarbamol 500 MG Oral Tablet

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �33

Page 34: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

197944 Methocarbamol 750 MG Oral Tablet197945 Aspirin 325 MG / Methocarbamol 400 MG Oral Tablet197956 Methyldopa 250 MG Oral Tablet197958 Methyldopa 500 MG Oral Tablet197960 Hydrochlorothiazide 25 MG / Methyldopa 250 MG Oral Tablet197963 Hydrochlorothiazide 15 MG / Methyldopa 250 MG Oral Tablet198032 Nifedipine 10 MG Oral Capsule198033 Nifedipine 20 MG Oral Capsule198083 Phenobarbital 100 MG Oral Tablet198085 Phenobarbital 16 MG Oral Tablet198086 Phenobarbital 16.2 MG Oral Tablet198089 Phenobarbital 60 MG Oral Tablet198270 Thioridazine 100 MG Oral Tablet198274 Thioridazine 25 MG Oral Tablet198275 Thioridazine 50 MG Oral Tablet198276 thyroid (USP) 120 MG Oral Capsule198277 thyroid (USP) 130 MG Oral Tablet198278 thyroid (USP) 180 MG Oral Tablet198280 thyroid (USP) 60 MG Oral Capsule198368 Phenobarbital 65 MG/ML Injectable Solution199164 Phenobarbital 97.2 MG Oral Tablet199167 Phenobarbital 32.4 MG Oral Tablet199168 Phenobarbital 64.8 MG Oral Tablet199208 thyroid (USP) 64.8 MG Oral Tablet199314 Dipyridamole 100 MG Oral Tablet199329 Nifedipine 5 MG Oral Capsule199340 Mephobarbital 60 MG Oral Tablet199341 Mephobarbital 200 MG Oral Tablet199549 Indomethacin 100 MG Rectal Suppository199782 Nifedipine 20 MG Oral Tablet199820 Trimipramine 25 MG Oral Tablet200330 thyroid (USP) 30 MG Oral Capsule200331 thyroid (USP) 90 MG Oral Capsule200332 thyroid (USP) 240 MG Oral Capsule200335 thyroid (USP) 32.4 MG Oral Tablet205333 Estradiol 1.5 MG Oral Tablet208545 thyroid (USP) 120 MG Oral Tablet238003 168 HR Estradiol 0.00208 MG/HR Transdermal Patch238004 168 HR Estradiol 0.00417 MG/HR Transdermal Patch238006 Estrogens, Esterified (USP) 0.625 MG / Methyltestosterone 1.25 MG Oral Tablet238090 Pentobarbital 50 MG/ML Injectable Solution238133 Pentazocine 30 MG/ML Injectable Solution238134 Aspirin 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule238135 Aspirin 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet238153 Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule238154 Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet240093 Acetaminophen 500 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet240826 dexbrompheniramine 2 MG Oral Tablet241527 168 HR Estradiol 0.00312 MG/HR Transdermal Patch241946 84 HR Estradiol 0.00156 MG/HR Transdermal Patch242333 168 HR Estradiol 0.00104 MG/HR Transdermal Patch242891 84 HR Estradiol 0.00208 MG/HR Transdermal Patch242892 84 HR Estradiol 0.00417 MG/HR Transdermal Patch245373 Trimipramine 50 MG Oral Tablet248478 84 HR Estradiol 0.00104 MG/HR Transdermal Patch282462 Phenobarbital 30 MG/ML Injectable Solution282463 Phenobarbital 60 MG/ML Injectable Solution

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �34

Page 35: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

284437 thyroid (USP) 15 MG Oral Capsule284438 thyroid (USP) 180 MG Oral Capsule308169 Amobarbital 200 MG Oral Capsule308170 Amobarbital Sodium 500 MG Injection308322 Acetaminophen 500 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule309232 Chlorpheniramine 4 MG / Phenylephrine 20 MG Extended Release Oral Tablet309243 Chlorpheniramine 12 MG Extended Release Oral Capsule309249 Chlorpheniramine 8 MG Extended Release Oral Capsule309952 Dipyridamole 25 MG Oral Tablet309955 Dipyridamole 75 MG Oral Tablet309958 Disopyramide 100 MG Oral Capsule309960 Disopyramide 150 MG Oral Capsule310143 ergoloid mesylates, USP 1 MG/ML Oral Solution310187 Estradiol 5 MG/ML Injectable Solution310197 Estrogens, Conjugated (USP) 0.625 MG Oral Tablet310203 Estrogens, Conjugated (USP) 5 MG/ML Injectable Solution310204 synthetic conjugated estrogens, A 0.625 MG Oral Tablet310205 synthetic conjugated estrogens, A 0.9 MG Oral Tablet310206 synthetic conjugated estrogens, A 1.25 MG Oral Tablet310212 estropipate 0.75 MG Oral Tablet310213 estropipate 1.5 MG Oral Tablet310215 estropipate 3 MG Oral Tablet310534 Glyburide 2.5 MG Oral Tablet310536 Glyburide 3 MG Oral Tablet310537 Glyburide 5 MG Oral Tablet310539 Glyburide 6 MG Oral Tablet310991 Indomethacin 5 MG/ML Oral Suspension310992 Indomethacin 75 MG Extended Release Oral Capsule312288 Acetaminophen 650 MG / Pentazocine 25 MG Oral Tablet312289 Naloxone 0.5 MG / Pentazocine 50 MG Oral Tablet312357 Phenobarbital 15 MG Oral Tablet312362 Phenobarbital 30 MG Oral Tablet312370 Phenobarbital 130 MG/ML Injectable Solution312914 Secobarbital 100 MG Oral Capsule313354 Thioridazine 10 MG Oral Tablet313385 thyroid (USP) 240 MG Oral Tablet313386 thyroid (USP) 260 MG Oral Tablet313387 thyroid (USP) 30 MG Oral Tablet313389 thyroid (USP) 325 MG Oral Tablet313391 thyroid (USP) 60 MG Oral Tablet313393 thyroid (USP) 90 MG Oral Tablet313396 thyroid (USP) 65 MG Oral Tablet313406 Ticlopidine Hydrochloride 250 MG Oral Tablet313496 Trimipramine 100 MG Oral Capsule313497 Trimipramine 100 MG Oral Tablet313498 Trimipramine 25 MG Oral Capsule313499 Trimipramine 50 MG Oral Capsule314000 Glyburide 1.5 MG Oral Tablet314132 Nifedipine 10 MG Oral Tablet314267 thyroid (USP) 15 MG Oral Tablet315234 thyroid (USP) 195 MG Oral Tablet315235 thyroid (USP) 300 MG Oral Tablet318179 ergoloid mesylates, USP 1 MG Oral Tablet346508 Indomethacin 1 MG/ML Injectable Solution346713 Thioridazine 25 MG/ML Oral Suspension346714 Thioridazine 100 MG/ML Oral Suspension347151 thyroid (USP) 32.5 MG Oral Tablet

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �35

Page 36: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

348906 Estradiol 1 MG / norgestimate 0.09 MG Oral Tablet349533 Brompheniramine 2.4 MG/ML Oral Suspension

349563 Chlorpheniramine 0.8 MG/ML / Methscopolamine 0.25 MG/ML / Phenylephrine 2 MG/ML Oral Solution

351228 synthetic conjugated estrogens, A 0.3 MG Oral Tablet351254 metaxalone 800 MG Oral Tablet359281 12 HR Brompheniramine 6 MG Extended Release Oral Tablet391980 Nifedipine 30 MG Oral Tablet402242 Estradiol 0.00208 MG/HR Topical Lotion402250 168 HR Estradiol 0.00188 MG/HR / Levonorgestrel 0.000625 MG/HR Transdermal Patch403849 Estrogens, Conjugated (USP) 0.45 MG Oral Tablet403922 168 HR Estradiol 0.00156 MG/HR Transdermal Patch403923 168 HR Estradiol 0.0025 MG/HR Transdermal Patch425319 Brompheniramine 0.4 MG/ML / Phenylephrine 1.5 MG/ML Oral Solution476540 synthetic conjugated estrogens, A 0.45 MG Oral Tablet476545 168 HR Estradiol 0.000583 MG/HR Transdermal Patch477587 24 HR Brompheniramine 12 MG Extended Release Oral Capsule483169 Estradiol 0.9 MG Oral Tablet485607 Brompheniramine 0.8 MG/ML Oral Suspension487079 Chlorpheniramine 0.8 MG/ML / Phenylephrine 4 MG/ML Oral Suspension542947 Brompheniramine 1 MG/ML / Pseudoephedrine 12.5 MG/ML Oral Solution544218 Chlorpheniramine 2 MG/ML Oral Suspension577027 Estradiol 0.45 MG Oral Tablet577029 Estradiol 1.8 MG Oral Tablet577154 Megestrol Acetate 125 MG/ML Oral Suspension584640 Brompheniramine Tannate 1.6 MG/ML Extended Release Suspension597658 Brompheniramine 0.8 MG/ML / Phenylephrine 1.5 MG/ML Oral Solution602598 drospirenone 0.5 MG / Ethinyl Estradiol 1 MG Oral Tablet603806 carbetapentane 6 MG/ML / Chlorpheniramine 0.8 MG/ML Oral Suspension618368 synthetic conjugated estrogens, B 0.3 MG Oral Tablet618370 synthetic conjugated estrogens, B 0.45 MG Oral Tablet618376 synthetic conjugated estrogens, B 0.625 MG Oral Tablet618378 synthetic conjugated estrogens, B 1.25 MG Oral Tablet636793 12 HR Disopyramide 100 MG Extended Release Oral Capsule636794 12 HR Disopyramide 150 MG Extended Release Oral Capsule647171 Chlorpheniramine 1.6 MG/ML Extended Release Suspension647172 Chlorpheniramine 1.6 MG/ML / Phenylephrine 2 MG/ML Extended Release Suspension688507 Estradiol 2.5 MG/ML Topical Lotion700850 Brompheniramine 1 MG/ML / Pseudoephedrine 7.5 MG/ML Oral Solution700851 Brompheniramine 1 MG/ML Oral Solution701393 dexchlorpheniramine 2 MG Extended Release Oral Tablet702220 dexchlorpheniramine 0.4 MG/ML Oral Solution702519 Phenobarbital 4 MG/ML Oral Solution

704848 dexchlorpheniramine 0.6 MG/ML / Pseudoephedrine 10 MG/ML Extended Release Suspension

707680 Chlorpheniramine 2 MG/ML / Phenylephrine 6 MG/ML Extended Release Suspension728118 Estradiol 1.53 MG/ACTUAT Topical Spray728581 thyroid (USP) 16.25 MG Oral Tablet730794 Carisoprodol 250 MG Oral Tablet730878 synthetic conjugated estrogens, B 0.9 MG Oral Tablet731007 Brompheniramine 6 MG / Phenylephrine 19 MG Extended Release Oral Tablet731032 12 HR Brompheniramine 11 MG Extended Release Oral Tablet

749850 {15 (Estradiol 1 MG / norgestimate 0.09 MG Oral Tablet) / 15 (Estradiol 1 MG Oral Tablet) } Pack

755584 Brompheniramine 0.4 MG/ML / Dextromethorphan 1 MG/ML / Phenylephrine 2 MG/ML Oral Solution

756245 Acetaminophen 21.7 MG/ML / butalbital 3.33 MG/ML / Caffeine 2.67 MG/ML Oral Solution756268 Brompheniramine 0.4 MG/ML / Pseudoephedrine 3 MG/ML Oral Solution

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �36

Page 37: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

828299 Cyclobenzaprine hydrochloride 7.5 MG Oral Tablet828320 Cyclobenzaprine hydrochloride 5 MG Oral Tablet828348 Cyclobenzaprine hydrochloride 10 MG Oral Tablet828353 24 HR Cyclobenzaprine hydrochloride 30 MG Extended Release Oral Capsule828358 24 HR Cyclobenzaprine hydrochloride 15 MG Extended Release Oral Capsule834022 Ketorolac Tromethamine 10 MG Oral Tablet835564 Imipramine Hydrochloride 25 MG Oral Tablet835568 Imipramine Hydrochloride 50 MG Oral Tablet835572 Imipramine pamoate 75 MG Oral Capsule835577 Imipramine pamoate 150 MG Oral Capsule835589 Imipramine pamoate 125 MG Oral Capsule835591 Imipramine pamoate 100 MG Oral Capsule835593 Imipramine Hydrochloride 10 MG Oral Tablet856706 Amitriptyline Hydrochloride 10 MG / Perphenazine 2 MG Oral Tablet856720 Amitriptyline Hydrochloride 10 MG / Perphenazine 4 MG Oral Tablet856762 Amitriptyline Hydrochloride 100 MG Oral Tablet856769 Amitriptyline Hydrochloride 12.5 MG / Chlordiazepoxide 5 MG Oral Tablet856773 Amitriptyline Hydrochloride 150 MG Oral Tablet856783 Amitriptyline Hydrochloride 10 MG Oral Tablet856792 Amitriptyline Hydrochloride 25 MG / Chlordiazepoxide 10 MG Oral Tablet856797 Amitriptyline Hydrochloride 25 MG / Perphenazine 2 MG Oral Tablet856825 Amitriptyline Hydrochloride 25 MG / Perphenazine 4 MG Oral Tablet856834 Amitriptyline Hydrochloride 25 MG Oral Tablet856840 Amitriptyline Hydrochloride 50 MG / Perphenazine 4 MG Oral Tablet856845 Amitriptyline Hydrochloride 50 MG Oral Tablet856853 Amitriptyline Hydrochloride 75 MG Oral Tablet857291 Clomipramine Hydrochloride 10 MG Oral Tablet857296 Clomipramine Hydrochloride 25 MG Oral Tablet857297 Clomipramine Hydrochloride 25 MG Oral Capsule857301 Clomipramine Hydrochloride 50 MG Oral Capsule857305 Clomipramine Hydrochloride 75 MG Oral Capsule857315 Clomipramine Hydrochloride 50 MG Oral Tablet857416 Clemastine Fumarate 1.34 MG Oral Tablet857430 Clemastine Fumarate 0.134 MG/ML Oral Solution857461 Clemastine Fumarate 2.68 MG Oral Tablet859003 Chlorpheniramine 0.4 MG/ML / Hydrocodone Bitartrate 0.5 MG/ML Oral Solution860092 1 ML Ketorolac Tromethamine 15 MG/ML Injection860096 Ketorolac Tromethamine 30 MG/ML Injectable Solution860113 1 ML Ketorolac Tromethamine 15 MG/ML Prefilled Syringe860114 1 ML Ketorolac Tromethamine 30 MG/ML Prefilled Syringe860115 2 ML Ketorolac Tromethamine 30 MG/ML Prefilled Syringe860215 Megestrol Acetate 20 MG Oral Tablet860221 Megestrol Acetate 40 MG Oral Tablet860225 Megestrol Acetate 40 MG/ML Oral Suspension860231 Megestrol Acetate 160 MG Oral Tablet860792 1 ML Meperidine Hydrochloride 75 MG/ML Cartridge861447 Meperidine Hydrochloride 10 MG/ML Injectable Solution861455 Meperidine Hydrochloride 100 MG Oral Tablet861459 Meperidine Hydrochloride 100 MG/ML Injectable Solution861463 Meperidine Hydrochloride 50 MG/ML Injectable Solution861467 Meperidine Hydrochloride 50 MG Oral Tablet861473 1 ML Meperidine Hydrochloride 50 MG/ML Cartridge861476 1 ML Meperidine Hydrochloride 25 MG/ML Injection861479 Meperidine Hydrochloride 10 MG/ML Oral Solution861482 1 ML Meperidine Hydrochloride 75 MG/ML Injection861493 1 ML Meperidine Hydrochloride 100 MG/ML Cartridge861494 1 ML Meperidine Hydrochloride 25 MG/ML Cartridge

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �37

Page 38: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

861578 Meperidine Hydrochloride 50 MG / Promethazine Hydrochloride 25 MG Oral Capsule861743 Glyburide 1.25 MG / Metformin hydrochloride 250 MG Oral Tablet861748 Glyburide 2.5 MG / Metformin hydrochloride 500 MG Oral Tablet861753 Glyburide 5 MG / Metformin hydrochloride 500 MG Oral Tablet862006 24 HR Guanfacine 1 MG Extended Release Oral Tablet862013 24 HR Guanfacine 2 MG Extended Release Oral Tablet862019 24 HR Guanfacine 3 MG Extended Release Oral Tablet862025 24 HR Guanfacine 4 MG Extended Release Oral Tablet866021 Cyproheptadine hydrochloride 0.4 MG/ML Oral Solution866144 Cyproheptadine hydrochloride 4 MG Oral Tablet882504 Diphenhydramine Hydrochloride 12.5 MG Disintegrating Oral Tablet885209 benztropine mesylate 2 MG Oral Tablet885213 benztropine mesylate 1 MG Oral Tablet885219 benztropine mesylate 0.5 MG Oral Tablet889520 Acetaminophen 300 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule891445 12 HR dexchlorpheniramine 6 MG / Phenylephrine 40 MG Extended Release Oral Tablet895560 12 HR dexchlorpheniramine 3 MG / Phenylephrine 20 MG Extended Release Oral Tablet895664 Diphenhydramine Citrate 38 MG / Ibuprofen 200 MG Oral Tablet901814 Diphenhydramine Hydrochloride 25 MG / Ibuprofen 200 MG Oral Capsule905269 Trihexyphenidyl Hydrochloride 2 MG Oral Tablet905273 Trihexyphenidyl Hydrochloride 0.4 MG/ML Oral Solution905283 Trihexyphenidyl Hydrochloride 5 MG Oral Tablet978944 dienogest 2 MG / estradiol valerate 2 MG Oral Tablet978946 dienogest 3 MG / estradiol valerate 2 MG Oral Tablet991042 dexchlorpheniramine 2 MG / Phenylephrine 10 MG Oral Tablet991486 Codeine Phosphate 2 MG/ML / Promethazine Hydrochloride 1.25 MG/ML Oral Solution991528 Dextromethorphan 3 MG/ML / Promethazine Hydrochloride 1.25 MG/ML Oral Solution992432 Promethazine Hydrochloride 1.25 MG/ML Oral Solution992438 Promethazine Hydrochloride 12.5 MG Oral Tablet992447 Promethazine Hydrochloride 25 MG Oral Tablet992475 Promethazine Hydrochloride 50 MG Oral Tablet992900 Promethazine Hydrochloride 10 MG Oral Tablet

993943 Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule

994012 Acetaminophen 500 MG / Chlorpheniramine 4 MG / Codeine Phosphate 20 MG Oral Tablet994226 Aspirin 325 MG / Carisoprodol 200 MG / Codeine Phosphate 16 MG Oral Tablet

994237 Aspirin 325 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule

994521 12 HR Orphenadrine Citrate 100 MG Extended Release Oral Tablet994528 Aspirin 385 MG / Caffeine 30 MG / Orphenadrine Citrate 25 MG Oral Tablet994535 Aspirin 770 MG / Caffeine 60 MG / Orphenadrine Citrate 50 MG Oral Tablet994541 Orphenadrine Citrate 30 MG/ML Injectable Solution994824 Orphenadrine Hydrochloride 50 MG Oral Tablet994841 Orphenadrine Citrate 100 MG Oral Tablet995062 Chlorpheniramine 0.2 MG/ML / Codeine Phosphate 1 MG/ML Oral Suspension995082 Chlorpheniramine 0.267 MG/ML / Codeine Phosphate 1 MG/ML Oral Suspension995123 Chlorpheniramine 0.4 MG/ML / Codeine Phosphate 1 MG/ML Oral Suspension995128 Chlorpheniramine 0.4 MG/ML / Codeine Phosphate 1.8 MG/ML Oral Solution995211 Chlorpheniramine 4 MG / Codeine Phosphate 10 MG Oral Tablet995214 Chlorpheniramine 4 MG / Codeine Phosphate 20 MG Oral Tablet995218 Hydroxyzine Hydrochloride 10 MG Oral Tablet995232 Hydroxyzine Pamoate 100 MG Oral Capsule995235 Hydroxyzine Hydrochloride 100 MG Oral Tablet995241 Hydroxyzine Hydrochloride 2 MG/ML Oral Solution995253 Hydroxyzine Pamoate 25 MG Oral Capsule995258 Hydroxyzine Hydrochloride 25 MG Oral Tablet995274 Hydroxyzine Pamoate 5 MG/ML Oral Suspension995278 Hydroxyzine Pamoate 50 MG Oral Capsule

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �38

Page 39: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

995281 Hydroxyzine Hydrochloride 50 MG Oral Tablet995428 Hydroxyzine Pamoate 10 MG Oral Capsule

996640 Codeine Phosphate 2 MG/ML / Pseudoephedrine Hydrochloride 6 MG/ML / Triprolidine Hydrochloride 0.25 MG/ML Oral Solution

996757 Codeine Phosphate 2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML / Promethazine Hydrochloride 1.25 MG/ML Oral Solution

997008 Chlorpheniramine Maleate 0.4 MG/ML / Codeine Phosphate 2 MG/ML Oral Solution

997156 Codeine Phosphate 1.5 MG/ML / Diphenhydramine Hydrochloride 2.5 MG/ML / Phenylephrine Hydrochloride 1.5 MG/ML Oral Solution

997272 Codeine Phosphate 2 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML / Triprolidine Hydrochloride 0.25 MG/ML Oral Solution

998254 Chlorpheniramine Maleate 4 MG / Pseudoephedrine Hydrochloride 60 MG Oral Tablet

998369 Codeine Phosphate 2 MG/ML / Dexchlorpheniramine maleate 0.2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution

999731 Cyclobenzaprine hydrochloride 10 MG / Magnesium Oxide 200 MG Oral Capsule

DescriptionRxNORM Code

2017 Clinical Quality Measures January 13, 2017 �39

Page 40: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix C: High-Risk Medications for the Elderly with Days Supply Criteria

RxNORM Code Description

1232194 Zolpidem tartrate 1.75 MG Sublingual Tablet

1232202 Zolpidem tartrate 3.5 MG Sublingual Tablet

1648755 NITROFURANTOIN, MACROCRYSTALS 25 MG / Nitrofurantoin, Monohydrate 75 MG Oral Capsule

1648759 NITROFURANTOIN, MACROCRYSTALS 100 MG Oral Capsule

311989 Nitrofurantoin 5 MG/ML Oral Suspension

311991 Nitrofurantoin 50 MG Oral Tablet

311994 NITROFURANTOIN, MACROCRYSTALS 25 MG Oral Capsule

311995 NITROFURANTOIN, MACROCRYSTALS 50 MG Oral Capsule

313761 zaleplon 10 MG Oral Capsule

313762 zaleplon 5 MG Oral Capsule

485440 Eszopiclone 1 MG Oral Tablet

485442 Eszopiclone 2 MG Oral Tablet

485465 Eszopiclone 3 MG Oral Tablet

828692 Zolpidem tartrate 5 MG/ACTUAT Oral Spray

836641 Zolpidem tartrate 10 MG Sublingual Tablet

836647 Zolpidem tartrate 5 MG Sublingual Tablet

854873 Zolpidem tartrate 10 MG Oral Tablet

854876 Zolpidem tartrate 5 MG Oral Tablet

854880 Zolpidem tartrate 12.5 MG Extended Release Oral Tablet

854894 Zolpidem tartrate 6.25 MG Extended Release Oral Tablet

2017 Clinical Quality Measures January 13, 2017 �40

Page 41: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix D: SNOMED Codes for Cataract Surgery

SNOMED code Description

10178000 Extracapsular extraction of cataract by inferior temporal route (procedure)

110473004 Cataract surgery (procedure)

112963003 Aspiration of cataract (procedure)

112964009 Extraction of cataract by rotoextraction with aspiration (procedure)

12163000 Needling of secondary cataract (procedure)

231744001 Cataract extraction, insertion of intraocular lens and trabeculectomy (procedure)

308694002 Extracapsular cataract extraction and insertion of intraocular lens (procedure)

308695001 Intracapsular cataract extraction and insertion of intraocular lens (procedure)

313999004 Small incision phacoemulsification of cataract and insertion of intraocular lens (procedure)

31705006 Extraction of cataract by rotoextraction with aspiration by posterior route (procedure)

335636001 Extraction of primary membranous cataract by phacofragmentation (procedure)

336651000 Extraction of primary membranous cataract by mechanical fragmentation (procedure)

35717002 Discission of congenital cataract (procedure)

361191005 Extraction of cataract by ultrasonic phacofragmentation (procedure)

385468004 Cataract extraction and insertion of intraocular lens (procedure)

39243005 Mechanical fragmentation of cataract with extraction by posterior route (procedure)

397544007 Complicated cataract surgery (procedure)

404628003 Intracapsular cataract extraction (procedure)

415089008 Phacoemulsification of cataract with intraocular lens implantation (procedure)

417493007 Small incision manual extracapsular cataract extraction (procedure)

418430006 Bimanual phacoemulsification of cataract with intraocular lens implantation (procedure)

419767009 Bimanual microincisional phacoemulsification of cataract with intraocular lens implantation (procedure)

420260004 Bimanual phacoemulsification (procedure)

420526005 Coaxial phacoemulsfication (procedure)

424945000 Torsional phacoemulsification (procedure)

SNOMED code

2017 Clinical Quality Measures January 13, 2017 �41

Page 42: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

446548003 Extraction of cataract and trabeculectomy (procedure)

46309001 Extraction of primary membranous cataract by excision (procedure)

46426006 Cryoextraction of cataract by inferior temporal route (procedure)

46562009 Incisional discission of secondary membranous cataract and anterior hyaloid (procedure)

50538003 Discission of membranous cataract, primary (procedure)

5130002 Extraction of primary membranous cataract by discission (procedure)

51839008 Extraction of primary membranous cataract by needling (procedure)

54885007 Extraction of cataract (procedure)

65812008 Removal of secondary membranous cataract with iridectomy (procedure)

67760003 Extracapsular extraction of cataract by rotoextraction with aspiration (procedure)

69360005 Extracapsular extraction of cataract by mechanical fragmentation with aspiration by posterior route (procedure)

74490003 Mechanical fragmentation of primary membranous cataract (procedure)

75814005 Erysiphake extraction of cataract by inferior temporal route (procedure)

79611007 Extracapsular extraction of cataract by curette evacuation (procedure)

82155009 Extracapsular extraction of cataract by emulsification with aspiration (procedure)

84149000 Aspiration of cataract by phacoemulsification (procedure)

85622008 Cryoextraction of cataract by intracapsular approach (procedure)

88282000 Extracapsular extraction of cataract by mechanical fragmentation with aspiration (procedure)

89153001 Extracapsular extraction of cataract by rotoextraction with aspiration by posterior route (procedure)

9137006 Discission of membranous cataract, secondary (procedure)

DescriptionSNOMED code

2017 Clinical Quality Measures January 13, 2017 �42

Page 43: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix E: ICD-10 Codes for Primary Open-Angle Glaucoma

ICD-10 Code Description

H40.10X0 Unspecified open-angle glaucoma, stage unspecified

H40.10X1 Unspecified open-angle glaucoma, mild stage

H40.10X2 Unspecified open-angle glaucoma, moderate stage

H40.10X3 Unspecified open-angle glaucoma, severe stage

H40.10X4 Unspecified open-angle glaucoma, indeterminate stage

H40.1110 Primary open-angle glaucoma, right eye, stage unspecified

H40.1111 Primary open-angle glaucoma, right eye, mild stage

H40.1112 Primary open-angle glaucoma, right eye, moderate stage

H40.1113 Primary open-angle glaucoma, right eye, severe stage

H40.1114 Primary open-angle glaucoma, right eye, indeterminate stage

H40.1120 Primary open-angle glaucoma, left eye, stage unspecified

H40.1121 Primary open-angle glaucoma, left eye, mild stage

H40.1122 Primary open-angle glaucoma, left eye, moderate stage

H40.1123 Primary open-angle glaucoma, left eye, severe stage

H40.1124 Primary open-angle glaucoma, left eye, indeterminate stage

H40.1130 Primary open-angle glaucoma, bilateral, stage unspecified

H40.1131 Primary open-angle glaucoma, bilateral, mild stage

H40.1132 Primary open-angle glaucoma, bilateral, moderate stage

H40.1133 Primary open-angle glaucoma, bilateral, severe stage

H40.1134 Primary open-angle glaucoma, bilateral, indeterminate stage

H40.1190 Primary open-angle glaucoma, unspecified eye, stage unspecified

H40.1191 Primary open-angle glaucoma, unspecified eye, mild stage

H40.1192 Primary open-angle glaucoma, unspecified eye, moderate stage

H40.1193 Primary open-angle glaucoma, unspecified eye, severe stage

H40.1194 Primary open-angle glaucoma, unspecified eye, indeterminate stage

H40.11X0 Primary open-angle glaucoma, stage unspecified

H40.11X1 Primary open-angle glaucoma, mild stage

H40.11X2 Primary open-angle glaucoma, moderate stage

H40.11X3 Primary open-angle glaucoma, severe stage

ICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �43

Page 44: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

H40.11X4 Primary open-angle glaucoma, indeterminate stage

H40.1210 Low-tension glaucoma, right eye, stage unspecified

H40.1211 Low-tension glaucoma, right eye, mild stage

H40.1212 Low-tension glaucoma, right eye, moderate stage

H40.1213 Low-tension glaucoma, right eye, severe stage

H40.1214 Low-tension glaucoma, right eye, indeterminate stage

H40.1220 Low-tension glaucoma, left eye, stage unspecified

H40.1221 Low-tension glaucoma, left eye, mild stage

H40.1222 Low-tension glaucoma, left eye, moderate stage

H40.1223 Low-tension glaucoma, left eye, severe stage

H40.1224 Low-tension glaucoma, left eye, indeterminate stage

H40.1230 Low-tension glaucoma, bilateral, stage unspecified

H40.1231 Low-tension glaucoma, bilateral, mild stage

H40.1232 Low-tension glaucoma, bilateral, moderate stage

H40.1233 Low-tension glaucoma, bilateral, severe stage

H40.1234 Low-tension glaucoma, bilateral, indeterminate stage

H40.1290 Low-tension glaucoma, unspecified eye, stage unspecified

H40.1291 Low-tension glaucoma, unspecified eye, mild stage

H40.1292 Low-tension glaucoma, unspecified eye, moderate stage

H40.1293 Low-tension glaucoma, unspecified eye, severe stage

H40.1294 Low-tension glaucoma, unspecified eye, indeterminate stage

H40.151 Residual stage of open-angle glaucoma, right eye

H40.152 Residual stage of open-angle glaucoma, left eye

H40.153 Residual stage of open-angle glaucoma, bilateral

H40.159 Residual stage of open-angle glaucoma, unspecified eye

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �44

Page 45: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix F: ICD-10 Codes for Diabetic Retinopathy

ICD-10 Code Description

E08.311 Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema

E08.319 Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema

E08.3211 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye

E08.3212 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye

E08.3213 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E08.3219 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E08.329 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema

E08.3291 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, right eye

E08.3292 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, left eye

E08.3293 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E08.3299 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E08.331 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema

E08.3311 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E08.3312 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E08.3313 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

E08.3319 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E08.339 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema

E08.3391 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E08.3392 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, left eye

E08.3393 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E08.3399 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

E08.341 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema

E08.3411 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, right eye

ICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �45

Page 46: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E08.3412 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, left eye

E08.3413 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E08.3419 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E08.349 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema

E08.3491 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, right eye

E08.3492 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, left eye

E08.3493 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E08.3499 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

E08.351 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema

E08.3511 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, right eye

E08.3512 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, left eye

E08.3513 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, bilateral

E08.3519 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, unspecified eye

E08.3521 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E08.3522 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E08.3523 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E08.3529 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E08.3531 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E08.3532 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E08.3533 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

E08.3539 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E08.3541 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

E08.3542 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E08.3543 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

E08.3549 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E08.3551 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, right eye

E08.3552 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, left eye

E08.3553 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, bilateral

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �46

Page 47: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E08.3559 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, unspecified eye

E08.359 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema

E08.3591 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, right eye

E08.3592 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, left eye

E08.3593 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, bilateral

E08.3599 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye

E09.311 Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema

E09.319 Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy without macular edema

E09.321 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema

E09.3211 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye

E09.3212 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye

E09.3213 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E09.3219 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E09.329 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema

E09.3291 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye

E09.3292 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye

E09.3293 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E09.3299 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E09.331 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema

E09.3311 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E09.3312 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E09.3313 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

E09.3319 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E09.339 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

E09.3391 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E09.3392 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

E09.3393 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E09.3399 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �47

Page 48: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E09.341 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema

E09.3411 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye

E09.3412 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

E09.3413 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E09.3419 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E09.349 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

E09.3491 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

E09.3492 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

E09.3493 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E09.3499 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

E09.351 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema

E09.3511 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye

E09.3512 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye

E09.3513 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral

E09.3519 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

E09.3521 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E09.3522 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E09.3523 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E09.3529 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E09.3531 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E09.3532 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E09.3533 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

E09.3539 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E09.3541 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

E09.3542 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E09.3543 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

E09.3549 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E09.3551 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, right eye

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �48

Page 49: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E09.3552 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, left eye

E09.3553 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

E09.3559 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

E09.359 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema

E09.3591 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

E09.3592 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

E09.3593 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral

E09.3599 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

E10.311 Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema

E10.319 Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema

E10.321 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema

E10.3211 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye

E10.3212 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye

E10.3213 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E10.3219 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E10.329 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema

E10.3291 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye

E10.3292 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye

E10.3293 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E10.3299 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E10.331 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema

E10.3311 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E10.3312 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E10.3313 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

E10.3319 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E10.339 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

E10.3391 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E10.3392 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �49

Page 50: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E10.3393 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E10.3399 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

E10.341 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema

E10.3411 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye

E10.3412 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

E10.3413 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E10.3419 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E10.349 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

E10.3491 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

E10.3492 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

E10.3493 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E10.3499 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

E10.351 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema

E10.3511 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye

E10.3512 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye

E10.3513 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral

E10.3519 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

E10.3521 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E10.3522 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E10.3523 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E10.3529 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E10.3531 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E10.3532 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E10.3533 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

E10.3539 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E10.3541 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

E10.3542 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E10.3543 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �50

Page 51: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E10.3549 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E10.3551 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, right eye

E10.3552 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, left eye

E10.3553 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

E10.3559 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

E10.359 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema

E10.3591 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

E10.3592 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

E10.3593 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral

E10.3599 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

E11.311 Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema

E11.319 Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema

E11.321 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema

E11.3211 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye

E11.3212 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye

E11.3213 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E11.3219 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E11.329 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema

E11.3291 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye

E11.3292 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye

E11.3293 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E11.3299 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E11.331 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema

E11.3311 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E11.3312 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E11.3313 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

E11.3319 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E11.339 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �51

Page 52: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E11.3391 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E11.3392 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

E11.3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E11.3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

E11.341 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema

E11.3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye

E11.3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

E11.3413 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E11.3419 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E11.349 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

E11.3491 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

E11.3492 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

E11.3493 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E11.3499 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

E11.351 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema

E11.3511 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye

E11.3512 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye

E11.3513 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral

E11.3519 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

E11.3521 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E11.3522 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E11.3523 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E11.3529 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E11.3531 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E11.3532 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E11.3533 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

E11.3539 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E11.3541 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �52

Page 53: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E11.3542 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E11.3543 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

E11.3549 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E11.3551 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye

E11.3552 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye

E11.3553 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

E11.3559 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

E11.359 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema

E11.3591 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

E11.3592 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

E11.3593 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral

E11.3599 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

E13.311 Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema

E13.319 Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema

E13.321 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema

E13.3211 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye

E13.3212 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye

E13.3213 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

E13.3219 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye

E13.329 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema

E13.3291 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye

E13.3292 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye

E13.3293 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

E13.3299 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye

E13.331 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema

E13.3311 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye

E13.3312 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

E13.3313 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �53

Page 54: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E13.3319 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

E13.339 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

E13.3391 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye

E13.3392 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

E13.3393 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

E13.3399 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

E13.341 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema

E13.3411 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye

E13.3412 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

E13.3413 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

E13.3419 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye

E13.349 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

E13.3491 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

E13.3492 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

E13.3493 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

E13.3499 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

E13.351 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema

E13.3511 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye

E13.3512 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye

E13.3513 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral

E13.3519 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

E13.3521 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye

E13.3522 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye

E13.3523 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

E13.3529 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye

E13.3531 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye

E13.3532 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

E13.3533 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �54

Page 55: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

E13.3539 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E13.3541 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

E13.3542 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

E13.3543 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral

E13.3549 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye

E13.3551 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, right eye

E13.3552 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, left eye

E13.3553 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

E13.3559 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

E13.359 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema

E13.3591 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

E13.3592 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

E13.3593 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral

E13.3599 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

DescriptionICD-10 Code

2017 Clinical Quality Measures January 13, 2017 �55

Page 56: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix G: Patient Reason Exception SNOMED Codes

SNOMED Code Description

105480006 Refusal of treatment by patient (situation)

160932005 Financial problem (finding)

160934006 Financial circumstances change (finding)

182890002 Patient requests alternative treatment (finding)

182895007 Drug declined by patient (situation)

182897004 Drug declined by patient - side effects (situation)

182900006 Drug declined by patient - patient beliefs (situation)

182902003 Drug declined by patient - cannot pay script (situation)

183944003 Procedure refused (situation)

183945002 Procedure refused for religious reason (situation)

184081006 Patient has moved away (finding)

185479006 Patient dissatisfied with result (finding)

185481008 Dissatisfied with doctor (finding)

224187001 Variable income (finding)

225928004 Patient self-discharge against medical advice (procedure)

258147002 Stopped by patient (situation)

266710000 Drugs not taken/completed (situation)

266966009 Family illness (situation)

275694009 Patient defaulted from follow-up (finding)

275936005 Patient noncompliance - general (situation)

281399006 Did not attend (finding)

310343007 Further opinion sought (finding)

373787003 Treatment delay - patient choice (finding)

385648002 Rejected by recipient (qualifier value)

406149000 Medication refused (situation)

408367005 Patient forgets to take medication (finding)

413310006 Patient non-compliant - refused access to services (situation)

413311005 Patient non-compliant - refused intervention / support (situation)

413312003 Patient non-compliant - refused service (situation)

416432009 Procedure not wanted (situation)

423656007 Income insufficient to buy necessities (finding)

424739004 Income sufficient to buy only necessities (finding)

443390004 Refused (qualifier value)

2017 Clinical Quality Measures January 13, 2017 �56

Page 57: Clinical quality measures, or CQMs, are statistics that seek to … · Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by

Appendix H: Medical Reason Exception SNOMED Codes

SNOMED Code Description

183932001 Procedure contraindicated (situation)

183964008 Treatment not indicated (situation)

183966005 Drug treatment not indicated (situation)

216952002 Failure in dosage (event)

266721009 Absent response to treatment (situation)

269191009 Late effect of medical and surgical care complication (disorder)

274512008 Drug therapy discontinued (situation)

31438003 Drug resistance (disorder)

35688006 Complication of medical care (disorder)

371133007 Treatment modification (procedure)

397745006 Medical contraindication (finding)

407563006 Treatment not tolerated (situation)

410534003 Not indicated (qualifier value)

410536001 Contraindicated (qualifier value)

416098002 Drug allergy (disorder)

416406003 Procedure discontinued (situation)

428119001 Procedure not indicated (situation)

445528004 Treatment changed (situation)

59037007 Drug intolerance (disorder)

62014003 Adverse reaction to drug (disorder)

79899007 Drug interaction (finding)

2017 Clinical Quality Measures January 13, 2017 �57